Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions.

Autor:	Coquant G; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Aguanno D; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Pham S; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Grellier N; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Thenet S; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Carrière V; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Grill JP; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France., Seksik P; Centre de Recherche Saint-Antoine, INSERM, Sorbonne Université, Paris 75012, France.
Jazyk:	angličtina
Zdroj:	World journal of gastroenterology [World J Gastroenterol] 2021 Nov 14; Vol. 27 (42), pp. 7247-7270.
DOI:	10.3748/wjg.v27.i42.7247
Abstrakt:	Bacteria are known to communicate with each other and regulate their activities in social networks by secreting and sensing signaling molecules called autoinducers, a process known as quorum sensing (QS). This is a growing area of research in which we are expanding our understanding of how bacteria collectively modify their behavior but are also involved in the crosstalk between the host and gut microbiome. This is particularly relevant in the case of pathologies associated with dysbiosis or disorders of the intestinal ecosystem. This review will examine the different QS systems and the evidence for their presence in the intestinal ecosystem. We will also provide clues on the role of QS molecules that may exert, directly or indirectly through their bacterial gossip, an influence on intestinal epithelial barrier function, intestinal inflammation, and intestinal carcinogenesis. This review aims to provide evidence on the role of QS molecules in gut physiology and the potential shared by this new player. Better understanding the impact of intestinal bacterial social networks and ultimately developing new therapeutic strategies to control intestinal disorders remains a challenge that needs to be addressed in the future. Competing Interests: Conflict-of-interest statement: Seksik P reports consulting fees from Abbvie, Takeda, Merck-MSD, Pfizer, Astellas, Janssen and Biocodex and grants from Biocodex and Janssen. These COIs are unrelated to the current presentation. All other authors declare no conflict of interests for this article. (©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu